MD3996C2 - Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1) - Google Patents

Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1)

Info

Publication number
MD3996C2
MD3996C2 MDA20090055A MD20090055A MD3996C2 MD 3996 C2 MD3996 C2 MD 3996C2 MD A20090055 A MDA20090055 A MD A20090055A MD 20090055 A MD20090055 A MD 20090055A MD 3996 C2 MD3996 C2 MD 3996C2
Authority
MD
Moldova
Prior art keywords
phenylthiosemicarbazonato
aquacopper
salicylidene
inhibitors
enzyme activity
Prior art date
Application number
MDA20090055A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3996B1 (en
Inventor
Аурелиан ГУЛЯ
Виктор ЦАПКОВ
Дональд ПОЙРИЕР
Елена ПАХОНЦУ
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20090055A priority Critical patent/MD3996C2/en
Publication of MD3996B1 publication Critical patent/MD3996B1/en
Publication of MD3996C2 publication Critical patent/MD3996C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to chemistry, namely to the synthesis of coordinative compounds from the class of thiosemicarbazonates of transition metals that can find their application in medicine for prophylaxis and treatment of prostate cancer.Summary of the invention consists in the synthesis of perchlorate of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) of general formula:where R=Br, NO2.The coordinative compounds possess properties of inhibitors of 17β-HSD enzyme activity (type 1), stimulator for prostate cancer cell proliferation.
MDA20090055A 2009-05-25 2009-05-25 Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1) MD3996C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20090055A MD3996C2 (en) 2009-05-25 2009-05-25 Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20090055A MD3996C2 (en) 2009-05-25 2009-05-25 Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1)

Publications (2)

Publication Number Publication Date
MD3996B1 MD3996B1 (en) 2009-12-31
MD3996C2 true MD3996C2 (en) 2010-07-31

Family

ID=43568860

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20090055A MD3996C2 (en) 2009-05-25 2009-05-25 Perchlorates of 5-R-salicylidene-4-phenylthiosemicarbazonato(1-)-aquacopper(II) possessing properties of inhibitors of 17b-HSD enzyme activity (type 1)

Country Status (1)

Country Link
MD (1) MD3996C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4126C1 (en) * 2010-11-15 2012-04-30 Государственный Университет Молд0 N,N'-[4,4'-(perfluoro-1,4-phenylenedioxy)-bis(4,1-phenylene)]-bis[2-(pyridine-2-ilmethylene)hydrazinecarbothioamide] and use thereof as prostate cancer LNCaP cell proliferation inhibitor
MD4132C1 (en) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4025C2 (en) * 2009-08-25 2010-10-31 Владимир КАРАУШ Remedy for treating prostatitis and prostate hyperplasia
MD4349C1 (en) * 2014-06-23 2015-12-31 Государственный Университет Молд0 N-(3-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide compound - inhibitor of human melanoma MeW-164 cell proliferation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695911A (en) * 1951-08-14 1954-11-30 American Home Prod Preparation of copper compounds of thiosemicarbazones
RU2265014C1 (en) * 2004-05-13 2005-11-27 Открытое Акционерное Общество "Фармасинтез" Method for preparing 4-thioureidoiminimethyl-pyridinium perchlorate possessing tuberculostatic activity
MD3771G2 (en) * 2008-04-30 2009-07-31 Государственный Университет Молд0 Inhibitors of 17β-HSD enzyme, stimulator for prostate cancer cell multiplication

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695911A (en) * 1951-08-14 1954-11-30 American Home Prod Preparation of copper compounds of thiosemicarbazones
RU2265014C1 (en) * 2004-05-13 2005-11-27 Открытое Акционерное Общество "Фармасинтез" Method for preparing 4-thioureidoiminimethyl-pyridinium perchlorate possessing tuberculostatic activity
MD3771G2 (en) * 2008-04-30 2009-07-31 Государственный Университет Молд0 Inhibitors of 17β-HSD enzyme, stimulator for prostate cancer cell multiplication

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4126C1 (en) * 2010-11-15 2012-04-30 Государственный Университет Молд0 N,N'-[4,4'-(perfluoro-1,4-phenylenedioxy)-bis(4,1-phenylene)]-bis[2-(pyridine-2-ilmethylene)hydrazinecarbothioamide] and use thereof as prostate cancer LNCaP cell proliferation inhibitor
MD4132C1 (en) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells

Also Published As

Publication number Publication date
MD3996B1 (en) 2009-12-31

Similar Documents

Publication Publication Date Title
MX2021011209A (en) Novel small molecule inhibitors of tead transcription factors.
PH12015502575B1 (en) Piperidin-4-yl azetidine derivatives as jak1 inhibitors
MX2013001970A (en) Pyrrolopyrimidine compounds and uses thereof.
MX2009013341A (en) 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives.
IN2012DN02081A (en)
PH12014502772A1 (en) Substituted tricyclic compounds as fgfr inhibitors
TW200800994A (en) Inhibitors of E1 activating enzymes
MX2009001309A (en) Heteroaryl compounds useful as inhibitors of e1 activating enzymes.
TW200942545A (en) Azetidine and cyclobutane derivatives as JAK inhibitors
MX2013008212A (en) 7-azaindole derivatives.
EA201101650A1 (en) NEW PYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF MALIGNANT NONFORMS AND THE FOLLOWING DISEASES
MY157124A (en) Substituted imidazopyridinyl-aminopyridine compounds
MX2013004491A (en) Boronates as arginase inhibitors.
MX2013004004A (en) Pyrrolidinones as metap2 inhibitors.
MX2012001419A (en) Novel bicyclic urea compounds.
MX2011009780A (en) Substituted pyrimidines for the treatment of cancer.
MX2013005751A (en) Quinazoline carboxamide azetidines.
MY151342A (en) Phenylamino isonicotinamide compounds
TW200700064A (en) Novel compounds
MX2011011083A (en) Heterocyclic compounds as mek inhibitors.
MX2012001413A (en) Novel azaheterocyclic compounds.
IL207310A0 (en) Vaccine compositions
MX2008001982A (en) O-nitro compounds, pharmaceutical compositons thereof and uses thereof.
WO2013152120A3 (en) Compositions and methods for promoting intestinal stem cell function
NZ611581A (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees